tiprankstipranks
Xvivo Perfusion AB (SE:XVIVO)
:XVIVO
Sweden Market
XVIVO
Xvivo Perfusion AB
RESEARCH TOOLSreports
Want to see SE:XVIVO full AI Analyst Report?

Xvivo Perfusion AB (XVIVO) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

XVIVO Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Xvivo
Perfusion AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

XVIVO Stock 12 Month Forecast

There Are No Analyst Ratings for SE:XVIVO In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

XVIVO Financial Forecast

XVIVO Earnings Forecast

Next quarter’s earnings estimate for XVIVO is kr0.80 with a range of kr0.64 to kr1.15. The previous quarter’s EPS was kr0.65. XVIVO beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year XVIVO has Outperformed its overall industry.
Next quarter’s earnings estimate for XVIVO is kr0.80 with a range of kr0.64 to kr1.15. The previous quarter’s EPS was kr0.65. XVIVO beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year XVIVO has Outperformed its overall industry.

XVIVO Sales Forecast

Next quarter’s sales forecast for XVIVO is kr237.57M with a range of kr229.00M to kr246.80M. The previous quarter’s sales results were kr238.99M. XVIVO beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year XVIVO has Outperformed its overall industry.
Next quarter’s sales forecast for XVIVO is kr237.57M with a range of kr229.00M to kr246.80M. The previous quarter’s sales results were kr238.99M. XVIVO beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year XVIVO has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - xAI Analyst forecast on SE:XVIVO
xAI - Grok-3
TipRanks - xAI
TipRanks - xAI
kr305
Hold
23.08%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on SE:XVIVO
Anthropic - Opus-4.1
TipRanks - Anthropic
TipRanks - Anthropic
kr284
Hold
14.61%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on SE:XVIVO
DeepSeek - R1-0528
TipRanks - DeepSeek
TipRanks - DeepSeek
kr305
Hold
23.08%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on SE:XVIVO
Gemini - 2.5Pro
TipRanks - Google
TipRanks - Google
kr301
Hold
21.47%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on SE:XVIVO
OpenAI - 4o
TipRanks - OpenAI
TipRanks - OpenAI
kr305
Hold
23.08%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on SE:XVIVO
PerPlexity - SonarPro
TipRanks - PerPlexity
TipRanks - PerPlexity
kr306
Hold
23.49%
Upside
Downgraded
08/10/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
AI Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - xAI Analyst forecast on SE:XVIVO
xAI - Grok-3
TipRanks - xAI
TipRanks - xAI
kr305
Hold
23.08%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on SE:XVIVO
Anthropic - Opus-4.1
TipRanks - Anthropic
TipRanks - Anthropic
kr284
Hold
14.61%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on SE:XVIVO
DeepSeek - R1-0528
TipRanks - DeepSeek
TipRanks - DeepSeek
kr305
Hold
23.08%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on SE:XVIVO
Gemini - 2.5Pro
TipRanks - Google
TipRanks - Google
kr301
Hold
21.47%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on SE:XVIVO
OpenAI - 4o
TipRanks - OpenAI
TipRanks - OpenAI
kr305
Hold
23.08%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on SE:XVIVO
PerPlexity - SonarPro
TipRanks - PerPlexity
TipRanks - PerPlexity
kr306
Hold
23.49%
Upside
Downgraded
08/10/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BTSGBrightSpring Health Services, Inc.
ACRVAcrivon Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
TNYATenaya Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

XVIVO Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, XVIVO has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. XVIVO average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

XVIVO Stock Forecast FAQ

What is SE:XVIVO’s average 12-month price target, according to analysts?
Currently, no data Available
What is SE:XVIVO’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SE:XVIVO, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Xvivo Perfusion AB a Buy, Sell or Hold?
      Currently, no data Available
      What is Xvivo Perfusion AB’s share price target?
      Currently, no data Available
      What do analysts say about Xvivo Perfusion AB?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Xvivo Perfusion AB?
      To buy shares of SE:XVIVO, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.